Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-22 · accession 0001209191-22-047210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-23 | 2022-08-22 | VNDA | Wijkstrom Joakim | SVP, CMO | S - Sale | $10.27 | -3,605 | 96.7K | -4% | -$37.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-22 | S | D | 3,605 | $10.27 | 96,673 | D | — | — |